Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.
| Non-Executive Director: |
Christian Schweiger |
| Non-Executive Chairman: |
Hans-Peter Hasler |
| Independent Non-Executive Director: |
Fabiana Lacerca Allen, Peter Llewellyn-Davies |
| Interim CEO: |
Anders Lundstrom |
| Address: |
Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom |
| Phone: |
+44 (0) 191 511 8500 |
| Fax: |
|
| Website: |
http://www.shieldtherapeutics.com/ |
| Email: |
|